PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 6 |
| 2014 | 14 |
| 2015 | 8 |
| 2016 | 15 |
| 2017 | 11 |
| 2018 | 22 |
| 2019 | 17 |
| 2020 | 19 |
| 2021 | 17 |
| 2022 | 16 |
| 2023 | 26 |
| 2024 | 20 |
| 2025 | 13 |
| 2026 | 12 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Melanoma Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival.
- Edmiston SN, Tsai YS, Corcoran DL, Hao H, Parrish EA, Googe PB, Shen R, Kuan PF, Ollila DW, Conway K, Thomas NE.
- Melanoma Res. Author manuscript. 2026 Jul 28;36(5):424-435. doi: 10.1097/CMR.0000000000001127.
- PMCID: PMC13537756
Edmiston SN, et al.Melanoma Res. Author manuscript. 2026.PMCID: PMC13537756 -
Association of chemokine and chemokine receptor gene variants with occurrence of multiple primary melanoma.
- Orlow I, Luo L, Autuori I, Mina I, Mauguen A, Edmiston SN, Gallagher RP, Ollila DW, Lee T, Busam K, Cust AE, Berwick M, Begg CB, Kanetsky PA, Thomas NE; GEM Study Group.
- Melanoma Res. Author manuscript. 2026 Aug 4;36(5):461-471. doi: 10.1097/CMR.0000000000001128.
- PMCID: PMC13505304
Orlow I, et al.Melanoma Res. Author manuscript. 2026.PMCID: PMC13505304 -
Immunotherapy for treatment of female genital tract melanoma: National Cancer Database analysis.
- Davidson SJ, Teoh DGK, Dudek AZ, Vogel RI.
- Melanoma Res. Author manuscript. 2025 Apr 1;35(4):242-251. doi: 10.1097/CMR.0000000000001036.
- PMCID: PMC12204789
Davidson SJ, et al.Melanoma Res. Author manuscript. 2025.PMCID: PMC12204789 -
Thinking beyond immunotherapy: implementing a multimodal care plan to facilitate extended survival in stage IV melanoma.
- Sreeram A, Postow MA, Moy AP, Ariyan CE, Bello DM.
- Melanoma Res. Author manuscript. 2025 Nov 10;36(1):64-69. doi: 10.1097/CMR.0000000000001072.
- PMCID: PMC13326683
Sreeram A, et al.Melanoma Res. Author manuscript. 2025.PMCID: PMC13326683 -
Novel uveal melanoma patient-derived cell line and organoid models show increased treatment resistance compared with commercially available cell lines.
- Dalvin LA, Burr SD, Miley DR, Ong H, Armitage JA.
- Melanoma Res. Author manuscript. 2026 Jun 24;36(4):328-333. doi: 10.1097/CMR.0000000000001103.
- PMCID: PMC13264505
Dalvin LA, et al.Melanoma Res. Author manuscript. 2026.PMCID: PMC13264505 -
Impact of systemic imaging surveillance on survival from metastatic uveal melanoma.
- Van Ryan V, Zahrieh D, Strand C, Churchill RA, Dalvin LA, Dudek AZ.
- Melanoma Res. Author manuscript. 2025 May 19;35(4):268-275. doi: 10.1097/CMR.0000000000001042.
- PMCID: PMC13261707
Van Ryan V, et al.Melanoma Res. Author manuscript. 2025.PMCID: PMC13261707 -
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.
- Tarhini AA, Khaksar MA, Chen Z, Lee SJ, Hodi FS, Li T, Monteiro AN, Streicher H, Sondak VK, Wang X, Kirkwood JM, Kanetsky PA.
- Melanoma Res. Author manuscript. 2026 Mar 12;36(3):189-196. doi: 10.1097/CMR.0000000000001087.
- PMCID: PMC13254891
Tarhini AA, et al.Melanoma Res. Author manuscript. 2026.PMCID: PMC13254891 -
Successful use of nivolumab and relatlimab as salvage therapy for metastatic uveal melanoma.
- Mynam RS, Menon N, Birbrair A, Ma VT.
- Melanoma Res. Author manuscript. 2025 May 27;35(5):352-356. doi: 10.1097/CMR.0000000000001045.
- PMCID: PMC12212964
Mynam RS, et al.Melanoma Res. Author manuscript. 2025.PMCID: PMC12212964 -
Outcomes and prognostic factors in melanoma patients with leptomeningeal disease: a retrospective cohort study.
- Aboelatta MA, Rezazadeh A, Sener U, Breen WG, Suleiman R, Dudek AZ.
- Melanoma Res. 2026 Apr 28;36(3):203-210. doi: 10.1097/CMR.0000000000001088.
- PMCID: PMC13124253
Aboelatta MA, et al.Melanoma Res. 2026.PMCID: PMC13124253 -
Prediction of progression of hepatic metastases from uveal melanoma using gadoxetic acid-enhanced magnetic resonance imaging.
- Lee JE, Lee S, Hwang JA, Choi SY, Moon JE.
- Melanoma Res. 2026 Apr 28;36(3):211-218. doi: 10.1097/CMR.0000000000001096.
- PMCID: PMC13124272
Lee JE, et al.Melanoma Res. 2026.PMCID: PMC13124272